Publications

This document updates the UNHSEIP Monitoring Framework, September 2009. Consistent with a maturing programme, the new framework shifts the focus of monitoring from the screening process to greater consideration of outcomes across the programme pathway and performance against international benchmarks. Indicators have been aligned with the change in the screening protocol to automated auditory brainstem response (aABR) screening only.

This statement outlines the National Screening Unit's position on screening for muscular dystrophy.

A report on testing for severe combined immune deficiency (SCID) in New Zealand as part of the Newborn Metabolic Screening Programme. It was prepared for the National Screening Unit by Health Partners Consulting Group Ltd.

This literature review was intended to inform an economic analysis of the cost-effectiveness of including testing for Severe Combined Immune Deficiency (SCID) in the Newborn Metabolic Screening Programme. It was prepared for the National Screening Unit by Health Partners Consulting Group Ltd.